Ironwood Pharmaceuticals IRWD Net Change in Cash
Net Change in Cash at other companies
Other financials
Where this comes from
Reported directly by Ironwood Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.
The official record: Ironwood Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ironwood Pharmaceuticals's net change in cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ironwood Pharmaceuticals's net change in cash?
- Ironwood Pharmaceuticals (IRWD) reported net change in cash of $5.02M in Q1 2026.
- How has Ironwood Pharmaceuticals's net change in cash changed year-over-year?
- Ironwood Pharmaceuticals's net change in cash decreased by 74.8% year-over-year, from $19.92M to $5.02M.
- What is the long-term trend for Ironwood Pharmaceuticals's net change in cash?
- Over 2 years (2021 to 2023), Ironwood Pharmaceuticals's net change in cash has grown at a 48.4% compound annual growth rate (CAGR), from $257.08M to -$565.78M.
- What does net change in cash mean?
- Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.